Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
J Clin Oncol. 2009 Jan 20; 27(3):398-403
Vickers AJ, Savage C, O'Brien MF, Lilja H. J Clin Oncol. 2009 Jan 20; 27(3):398-403
This recent overview concluded that prostate-specific antigen (PSA) kinetics, although predictive, did not add predictive value to absolute PSA values, and should not be used for decision-making in localized prostate cancer.
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.